Pfizer to appeal HUF 50 mln fine
pixabay
The Hungarian subsidiary of U.S.-based pharmaceuticals firm Pfizer has been fined HUF 50 million by the Hungarian Competition Authority (GVH) on charges of misleading advertising, news agency MTI reported Tuesday. The company will reportedly appeal.
The GVH charged the company for misleading advertising with regard to the effects of its Multi-tabs Multi Kid product, as the advertising suggested that the product can substitute for a balanced, varied diet for kids, thereby making an unsubstantiated claim for its health effects, MTI reported. When setting the fine, the authority took into account the cost of the advertising.
In a statement sent to MTI after the fine was announced, Pfizer Hungary said it would be appealing the GVHʼs decision in court as it believes the ruling is unsubstantiated and that Pfizerʼs advertising practices did not conflict with regulations.
Hungary CPI Drop Acknowledged at IMF/World Bank Spring Meeti...
Hungary to Address Future of Cohesion Policy During EU Presi...
AI may Save Hungarian Healthcare, Says Leading Doctor
Time Out Market to Open in Budapest Next Year
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
.jpg)
